Siddhartha Kadia

Siddhartha Kadia, Ph.D., has served as a member of the board of directors since February 2021. Dr. Kadia most recently served as president and CEO of EAG Laboratories, a global scientific services company providing analytical testing and consulting solutions. Prior to EAG Laboratories, Dr. Kadia spent nine years with Life Technologies Corporation and its predecessor Invitrogen Corporation. Dr. Kadia held various positions with increasing responsibilities, including marketing and operations roles, as well as leadership roles in Japan and China. Most notably, he served as President, Life Sciences Division at Life Technologies where he managed a $2 billion product portfolio. Prior to Life Technologies, Dr. Kadia was a management consultant at McKinsey & Company in the Healthcare Practice. Dr. Kadia currently serves as a member of the board of directors of ALS Limited and BioSkryb. Dr. Kadia earned a bachelor’s degree electronics and telecommunications from Gujarat University in India, a master’s degree in biomedical engineering from Rutgers University, and a doctor of philosophy in biomedical engineering from Johns Hopkins University.